atzanavir

— We quantified drug–drug interactions with the HIV Drug Interaction chart from the University of Liverpool, and contraindications between recommended first-line ART and NCDs were based on EACS guidelines. 22 The EACS-recommended regimens (as of October, 2013) consisted of a backbone of tenofovir/emtricitabine or abacavir/lamivudine combined with either efavirenz, rilpivirine, raltegravir or ritonavir-boosted atzanavir, darunavir, or lopinavir. 22 The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.